Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:13 PM
Ignite Modification Date:
2025-12-24 @ 10:13 PM
NCT ID:
NCT06369935
Eligibility Criteria:
Inclusion Criteria:
* Adult patients with confirmed relapsed/refractory multiple myeloma;
* Based on clinical practice, the physician decided to administer equecabtagene autoleucel treatment;
* Voluntarily sign the informed consent form approved by the ethics committee.
Exclusion Criteria:
* Patients who are hypersensitive to the active ingredients of the product or any excipients (dimethyl sulfoxide, compound electrolyte injection, human albumin);
* The researcher believes that patients are unable to return for follow-up visits or that it is impossible to complete the study;
* Patients with expected survival less than 3 months
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06369935
Study Brief:
Protocol Section:
NCT06369935